483 Covance Labs Sep 2017

483 Covance Labs Sep 2017

Peter Lenahan FDA$595.00 - Available Now

FDA investigators audited the Covance Labs - Somerset, NJ, United States facility and issued inspectional observations (via FDA 483) on 27 Sep 2017.

Product details

  • Category: Human Drugs
  • Inspection end: 27 Sep 2017
  • Location: Somerset, United States
  • FEI: 2218179
Add To Cart